Rafke Schoffelen

576 total citations
12 papers, 430 citations indexed

About

Rafke Schoffelen is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Rafke Schoffelen has authored 12 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Rafke Schoffelen's work include Radiopharmaceutical Chemistry and Applications (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Peptidase Inhibition and Analysis (4 papers). Rafke Schoffelen is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Peptidase Inhibition and Analysis (4 papers). Rafke Schoffelen collaborates with scholars based in Netherlands and United States. Rafke Schoffelen's co-authors include Winette T.A. van der Graaf, Carla M.L. van Herpen, Wim J.G. Oyen, Robert M. Sharkey, Otto C. Boerman, William J. McBride, David M. Goldenberg, Gerben M. Franssen, Piet J. Slootweg and Vera Mattijssen and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Journal of Clinical Pathology.

In The Last Decade

Rafke Schoffelen

12 papers receiving 423 citations

Peers

Countries citing papers authored by Rafke Schoffelen

Since Specialization

Citations

This map shows the geographic impact of Rafke Schoffelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafke Schoffelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafke Schoffelen more than expected).

Fields of papers citing papers by Rafke Schoffelen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafke Schoffelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafke Schoffelen. The network helps show where Rafke Schoffelen may publish in the future.

Co-authorship network of co-authors of Rafke Schoffelen

This figure shows the co-authorship network connecting the top 25 collaborators of Rafke Schoffelen. A scholar is included among the top collaborators of Rafke Schoffelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafke Schoffelen. Rafke Schoffelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Drug-drug interactions with aprepitant in antiemetic prophylaxis for chemotherapy. 2018 ·PubMed ·Rafke Schoffelen, (unknown), Carla M.L. van Herpen, Jacobus J. M. van der Hoeven, Ingrid M.E. Desar, Cornelis Kramers	10
2	Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy 2015 ·EJNMMI Physics ·(unknown), Rafke Schoffelen, Robert F. Hobbs, Martin Gotthardt, David M. Goldenberg, Robert M. Sharkey, Cornelis H. Slump, Winette T.A. van der Graaf, Wim J.G. Oyen, Otto C. Boerman, George Sgouros, Eric P. Visser	9
3	Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer 2014 ·European Journal of Nuclear Medicine and Molecular Imaging ·Rafke Schoffelen, (unknown), Eric P. Visser, David M. Goldenberg, Robert M. Sharkey, William J. McBride, Chien‐Hsing Chang, Edmund A. Rossi, Winette T.A. van der Graaf, Wim J.G. Oyen, Otto C. Boerman	29
4	Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results 2013 ·British Journal of Cancer ·Rafke Schoffelen, Otto C. Boerman, David M. Goldenberg, Robert M. Sharkey, Carla M.L. van Herpen, Gerben M. Franssen, William J. McBride, C.-H. Chang, Edmund A. Rossi, Winette T.A. van der Graaf, Wim J.G. Oyen	66
5	Quantitative Immuno-SPECT Monitoring of Pretargeted Radioimmunotherapy with a Bispecific Antibody in an Intraperitoneal Nude Mouse Model of Human Colon Cancer 2012 ·Journal of Nuclear Medicine ·Rafke Schoffelen, Winette T.A. van der Graaf, Robert M. Sharkey, Gerben M. Franssen, William J. McBride, Chien‐Hsing Chang, Desirée L. Bos, David M. Goldenberg, Wim J.G. Oyen, Otto C. Boerman	11
6	Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method 2012 ·EJNMMI Research ·Rafke Schoffelen, Winette T.A. van der Graaf, Robert M. Sharkey, Gerben M. Franssen, William J. McBride, Chien‐Hsing Chang, Peter Laverman, David M. Goldenberg, Wim J.G. Oyen, Otto C. Boerman	23
7	Phase I clinical study of pretargeted radioimmunotherapy (PRIT) in patients with colorectal cancer (CRC): An update 2012 ·Rafke Schoffelen, Winette van der Graaf, Robert M. Sharkey, Otto C. Boerman, Eric P. Visser, William J. McBride, (unknown), Chien‐Hsing Chang, David Goldenberg, Wim J.G. Oyen	1
8	Phase I clinical study of the feasibility of pretargeted radioimmunotherapy (PT-RAIT) in patients with colorectal cancer (CRC): First results 2011 ·Rafke Schoffelen, Otto C. Boerman, Winette van der Graaf, Carla van Herpen, Robert M. Sharkey, William J. McBride, Chien‐Hsing Chang, (unknown), David Goldenberg, Wim J.G. Oyen	6
9	Androgen Receptor–Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options 2011 ·Journal of Clinical Oncology ·(unknown), Berit M. Verbist, Rafke Schoffelen, Vera Mattijssen, Piet J. Slootweg, Winette T.A. van der Graaf, Carla M.L. van Herpen	127
10	Pretargeted ¹⁷⁷Lu Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colonic Tumors in Mice 2010 ·Journal of Nuclear Medicine ·Rafke Schoffelen, Winette T.A. van der Graaf, Gerben M. Franssen, Robert M. Sharkey, David M. Goldenberg, William J. McBride, Edmund A. Rossi, Annemarie Eek, Wim J.G. Oyen, Otto C. Boerman	37
11	Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts 2010 ·Molecular Cancer Therapeutics ·Rafke Schoffelen, Robert M. Sharkey, David M. Goldenberg, Gerben M. Franssen, William J. McBride, Edmund A. Rossi, Chien‐Hsing Chang, Peter Laverman, Jonathan A. Disselhorst, Annemarie Eek, Winette T.A. van der Graaf, Wim J.G. Oyen, Otto C. Boerman	75
12	Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer 2002 ·Journal of Clinical Pathology ·Mathie P.G. Leers, Rafke Schoffelen, (unknown), P Theunissen, J. Wolter Oosterhuis, (unknown), (unknown), Wei Tan, (unknown)	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact